<DOC>
<DOCNO>
EP-0011609
</DOCNO>
<TEXT>
<DATE>
19800528
</DATE>
<IPC-CLASSIFICATIONS>
C07D-473/04 A61K-31/519 C07D-239/00 C07D-473/00 A61K-31/52 A61P-9/00 A61K-31/522 C07D-473/06 A61P-11/08 A61P-11/00 C07D-239/54 C07D-239/545 <main>A61K-31/52</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease.
</TITLE>
<APPLICANT>
draco abse<sep>aktiebolaget draco<sep>aktiebolaget dracofacks-221 01 lund 1se<sep>aktiebolaget draco<sep>aktiebolaget±draco<sep>
</APPLICANT>
<INVENTOR>
kjellin per gunnar<sep>persson carl goran august<sep>kjellin, per gunnar<sep>persson, carl goran august<sep>kjellin, per gunnarspjutgränd 10s-223 75 lundse<sep>persson, carl göran augustslogstorps möllas-240 33 löberödse<sep>kjellin, per gunnar<sep>persson, carl goran august<sep>kjellin, per gunnar<sep>persson, carl goran august<sep>kjellin, per gunnarspjutgränd 10s-223 75 lundse<sep>persson, carl göran augustslogstorps möllas-240 33 löberödse<sep>
</INVENTOR>
<ABSTRACT>
a method for the treatment of chronic obstructive airway  disease or cardiac disease, characterized by the administra­ tion of a compound of the formula    wherein r is n-propyl, n-butyl or isobutyl or a therapeutically  acceptable salt thereof.  
</ABSTRACT>
</TEXT>
</DOC>
